Patent ID: 11939578
Assignee: BEIJING TIDE PHARMACEUTICAL CO., LTD.
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 0:
1. A pharmaceutical composition suitable for inhibiting casein kinase interacting protein 1 (CKIP-1) expression in a human subject in need thereof, which comprises:
(i) an amount of a double-stranded RNA (dsRNA) molecule comprising a sense strand shown in SEQ ID NO: 71 and an antisense strand shown in SEQ ID NO: 72 effective to inhibit the expression of CKIP-1 in a human subject in need thereof; and
(ii) a pharmaceutically acceptable carrier;
wherein said composition when administered to a human subject in need thereof is capable of inhibiting CKIP-1 expression.